Argenx to report full year 2020 financial results and fourth quarter business update on march 4, 2021

February 25, 2021 breda, the netherlands – argenx (euronext & nasdaq: argx), a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases and cancer, today announced that it will host a conference call and audio webcast on march 4, 2021 at 2:30 p.m. cet (8:30 a.m. et) to discuss its full year 2020 financial results and provide a fourth quarter business update.
ARGX Ratings Summary
ARGX Quant Ranking